TNFAIP3 and metabolic dysfunction-associated steatotic liver disease: It has also been reported that A20 attenuates liver cirrhosis in nonalcoholic fatty liver disease [109], and that SNVs in TNFAIP3 are associated with the severity of liver cirrhosis in patients with the human immunodeficiency virus and hepatitis C virus [110].